Alglucosidase alfa - PDFSEARCH.IO - Document Search Engine

Alglucosidase alfa
Results: 56

#	Item
1	LUMIZYME (alglucosidase alfa) for Injection Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-05-26 09:39:24 Clinical medicine Neurochemistry Medicine Sodium channel blockers Alglucosidase alfa Calcium channel blockers Glycogen storage disease type II Ketamine Treprostinil Eptifibatide
2	May 27, 2014 BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease Proprietary Glycosylation Independent Lysosomal Targeting (GILT) Tagging Technology Has Been Shown to Im Add to Reading List Source URL: www.apjohnventures.com Language: English - Date: 2014-05-29 15:30:33 Genetic genealogy BioMarin Pharmaceutical Glycogen storage disease type II Acid alpha-glucosidase Lysosomal storage disease Mucopolysaccharidosis Alglucosidase alfa Neuronal ceroid lipofuscinosis Tetrahydrobiopterin Health Rare diseases Medicine
3	PDF Document Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-01 21:56:22 Lysosomal storage diseases Orphan drugs Glycogen storage disease type II Hepatology Alglucosidase alfa Pharmaceutical Benefits Scheme Amyotrophic lateral sclerosis Clinical trial Health Medicine Rare diseases
4	Microsoft WordAlglucosidase Genzyme PSD March 2013 FINAL.doc Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-01 21:56:23 Lysosomal storage diseases Glycogen storage disease type II Hepatology Alglucosidase alfa Pharmaceutical Benefits Scheme Amyotrophic lateral sclerosis Clinical trial Health Medicine Rare diseases
5	Stakeholder meeting outcome statement Alglucosidase alfa (Myozyme®) for the treatment of Late-Onset Pompe Disease A stakeholder meeting was held on 9 October 2014 to discuss the development of eligibility guidelines for Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-12 23:53:04 Lysosomal storage diseases Glycogen storage disease type II Hepatology Alglucosidase alfa Medicine Health Rare diseases
6	United States Pompe Community Update - October 17, 2014 Genzyme would like to share with you an important update regarding the recent United States (U.S.) Food and Drug Administration’s (FDA) approval of an expanded la Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2014-10-20 09:46:41 Glycogen storage disease type II Hepatology Alglucosidase alfa Genzyme Anaphylaxis Allergy William Canfield Medicine Health Respiratory diseases
7	Genzyme Receives Label Expansion for Lumizyme® (alglucosidase alfa) in the United States for the treatment of Pompe Disease Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2014-09-18 20:12:24 Glycogen storage disease type II Genzyme Medicine Health Alglucosidase alfa
8	United States Pompe Community Update, August 1, 2014 Genzyme is pleased to provide an update to the Pompe Community regarding the recent United States (U.S.) Food and Drug Administration’s (FDA) approval of an expande Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2014-09-18 20:12:25 Hepatology Alglucosidase alfa Genzyme Anaphylaxis William Canfield Medicine Health Glycogen storage disease type II
9	THE HON SUSSAN LEY MP Minister for Health Minister for Sport MEDIA RELEASE 17 February 2015 Life-saving drug for young Pompe patients Add to Reading List Source URL: www.health.gov.au Language: English - Date: 2015-02-16 19:45:28 Rare diseases Glycogen storage disease type II Hepatology Alglucosidase alfa Genzyme Methadone William Canfield Medicine Health Lysosomal storage diseases
10	Proposed Text of The Labeling of The Drug Add to Reading List Source URL: www.lumizyme.com Language: English - Date: 2014-08-01 14:10:14 Glycogen storage disease type II Hepatology Alglucosidase alfa Hypersensitivity Anaphylaxis Medicine Health Allergology